Effect of vedolizumab dose intensification on serum drug concentrations and regain of response in inflammatory bowel disease patients with secondary loss of response

An Outtier  1     Jean François Rahier  2     Peter Bossuyt  3     Arnaud Colard  4     Denis Franchimont  5     Guy Lambrecht  6     Elisabeth Macken  7     Wouter Van Moerkercke  8     Filip Baert  9     Evelien Humblet  10     Philippe Van Hootegem     Ann Gils     Marc Ferrante     Severine Vermeire    
1 UZ Leuven,Leuven,Belgium
2 CHU UCL Mont-Godinne,Wavre,Belgium
3 Imelda Ziekenhuis,Bonheiden,Belgium
4 CHC Saint Joseph Hospital,Liège,Belgium
5 Free University of Brussels Erasme Hospital,Bruxelles,Belgium
6 AZ Damiaan,Oostende,Belgium
7 UZA,Edegem,Belgium
8 AZ Groeninge,Kortrijk,Belgium
9 Az Delta,Roeselare,Belgium
10 Ziekenhuis Oost Limbu

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing